The Retinal Biologics Market is making headlines for all the right reasons—offering new hope for millions battling vision-threatening conditions like age-related macular degeneration (AMD), diabetic retinopathy, and retinal vein occlusion. And if you're not keeping your eyes on this space, you're missing out on one of the biggest revolutions in modern medicine.